Intrastromal voriconazole: the next effective adjunctive treatment for recalcitrant keratomycosis.

Authors

  • Meenakshi Sindhu Department of Ophthalmology, Government Medical College & Hospital, Chandigarh-160030
  • Ravi Kant Bamotra Government Medical College & Hospital, Chandigarh
  • Shazia Qayum Maharishi Markandeshwar University, Mullana, Ambala, Haryana-133207

DOI:

https://doi.org/10.7439/ijbr.v7i5.3218

Keywords:

Delayed awakening, General anaesthesia, Drug effects, Neuromuscular blockers

Abstract

Introduction: Fungal keratitis is a commonly encountered infection of the cornea which may lead to moderate to severe visual loss. Aim: To report the result of intra-stromal voriconazole in refractory keratomycosis. Method: Fungal keratitis is a commonly encountered infection of the cornea which may lead to moderate to severe visual loss. It may be caused by several species of fungi and accounts for nearly 50% of all cases of infectious keratitis in developing countries. The penetration of antifungal drugs into the deeper layers of cornea is sub-optimal, thus making it difficult to treat cases of deep fungal keratitis. We report two cases of refractory fungal keratitis; one caused by aspergillus fumigates and other by fusarium as seen on lactophenol cotton blue mount from scrapings. Both the cases were resistant to topical 5% natamycin and 1 % voriconazole and therefore, intra-stromal voriconazole reconstituted to 50 microns / 0.1 ml was injected circumferentially into the mid-stroma in close proximity to the ulcer margins in both the cases. Result: A marked reduction in the size of ulcer (both epithelial defect and infiltrates) was noted at 72 hours after intra-stromal voriconazole. A repeat injection was given in both the cases four days after the first injection. No complications were seen in any of the cases. Conclusion: Intra-stromal voriconazole offers an effective adjunctive in treating refractory keratomycosis as the direct deposition of drug into deeper stroma results into higher therapeutic concentrations into ulcer; thus obviating the need for therapeutic penetrating keratoplasty in such patients.

Downloads

Download data is not yet available.

References

J. I. Ou and N. R. Acharya.

U. Gopinathan, S. Sharma, P. Garg, and G. Rao.

Polizzi A, Sinischalchi C. Effect of voriconazole on a corneal abscess caused by Fusarium. Acta Ophthalmol Scand 2004; 82:762-4.

Pfaller MA, Messer SA, Hollis RJ, Jones RN, Diekema DJ. In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp. Antimicrob Agents Chemother 2002; 46:1723-7.

Gao H, Pennesi M, Shah K, Qiao X, Hariprasad SM, Mieler WF et al. Safety of intravitreal voriconazole: electroretinographic and histopathologic studies. Trans Am Ophthalmol Soc 2003; 101:183-9.

Hariprasad SM, Mieler WF, Lin TK, Sponsel WE, Graybill JR. Voriconazole in the treatment of fungal eye infections: A review of current literature. Br J Ophthalmol 2008; 92(7):871-8.

Jurkunas U, Langston D, Colby K. Use of voriconazole in the treatment of fungal keratitis. Int Ophthalmol Clin 2007; 47(2):47

Kalaiselvi G , Narayana S , Krishnan T , Sengupta S. Intrastromal voriconazole for deep recalcitrant fungal keratitis: a case series. Br J Ophthalmol 2015 Feb?99 (2):195-8.

Prakash G, Sharma N, Goel M, Titiyal JS, Vajpayee RB. Evaluation of intrastromal injection of voriconazole as a therapeutic adjunctive for the management of deep recalcitrant fungal keratitis. Am J Ophthalmol 2008; 146:56-9.

Downloads

Published

2016-05-30

Issue

Section

Case Report

How to Cite

1.
Intrastromal voriconazole: the next effective adjunctive treatment for recalcitrant keratomycosis. Int Jour of Biomed Res [Internet]. 2016 May 30 [cited 2026 Feb. 16];7(5):299-302. Available from: https://ssjournals.co.in/index.php/ijbr/article/view/3218